Changes in SOLACI Authorities During SOLACI-SBHCI 2023 Congress

After a successful scientific event where all the most important topics in current interventional cardiology were addressed, there was a change in the authorities of the Latin American Society of Interventional Cardiology for the 2023-2025 term.

In this sense, Dr. Mario Araya (Chile)—a prestigious interventional cardiologist in our region, former Sessions Director, member of the SOLACI-LATAM Bif Registry and President of the Department of Hemodynamics of the Chilean Society of Cardiology (SOCHICAR) for 6 years—took the office of the SOLACI Presidency during the closing ceremony of the SOLACI-SBHCI 2023 Congress. He follows the successful work headed by Dr. Anibal Damonte, who led SOLACI with great effort and dedication over the past two years—a period marked by the end of the COVID-19 pandemic and the return to face-to-face events.

During his administration, Dr. Damonte led this return to face-to-face attendance at the SOLACI-SOCIME 2022 Congress, strengthened SOLACI’s links with regional and international institutions, enhanced our research records, and facilitated numerous educational and institutional activities, among which we can highlight the educational Webinars, the “MILs Train More MILs” Program, regional conferences in different Latin American countries, and the launching of the SOLACI Postgraduate Course in Hemodynamics for Technicians and Nurses. 

Dr. Araya—who worked side by side with Dr. Damonte over the past two years as SOLACI Vice-President—will ensure the continuity of all SOLACI projects, joined by Dr. Ricardo Costa (BRA) as Vice-President and Dr. Pedro Hidalgo (Venezuela) and Dr. Omar Santaera (Argentina), who remain in their roles as Secretary and Treasurer, respectively.

SOLACI will continue strengthening its institutional projects over time, fulfilling its mission to promote and expand continuing medical education in interventional cardiology in our continent.

We wish the best to the new Board of Directors!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

SOLACI Session at Miami Valves 2026

Once again, the Latin American Society of Interventional Cardiology will be present at one of the most important congresses worldwide in the field, with...

Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition

Registration is now open for the SOLACI–CACI Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition. The program is intended for physicians with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...